Cargando…

In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii

OBJECTIVES: Widespread antimicrobial resistance often limits the availability of therapeutic options to only a few last-resort drugs that are themselves challenged by emerging resistance and adverse side effects. Apramycin, an aminoglycoside antibiotic, has a unique chemical structure that evades al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juhas, Mario, Widlake, Emma, Teo, Jeanette, Huseby, Douglas L, Tyrrell, Jonathan M, Polikanov, Yury S, Ercan, Onur, Petersson, Anna, Cao, Sha, Aboklaish, Ali F, Rominski, Anna, Crich, David, Böttger, Erik C, Walsh, Timothy R, Hughes, Diarmaid, Hobbie, Sven N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419615/ https://www.ncbi.nlm.nih.gov/pubmed/30629184 http://dx.doi.org/10.1093/jac/dky546

Ejemplares similares

Importance of Co‐operative Hydrogen Bonding in the Apramycin‐Ribosomal Decoding A‐Site Interaction
por: Pirrone, Michael G., et al.
Publicado: (2022)

Model‐Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin
por: Sou, Tomás, et al.
Publicado: (2020)

Antibacterial activity of apramycin at acidic pH warrants wide therapeutic window in the treatment of complicated urinary tract infections and acute pyelonephritis
por: Becker, Katja, et al.
Publicado: (2021)

In Vitro Activity of Neomycin, Streptomycin, Paromomycin and Apramycin against Carbapenem-Resistant Enterobacteriaceae Clinical Strains
por: Hu, Ya, et al.
Publicado: (2017)

Synthesis, Antibacterial and Antiribosomal Activity of the 3C-Aminoalkyl Modification in the Ribofuranosyl Ring of Apralogs (5-O-Ribofuranosyl Apramycins)
por: Lubriks, Dmitrijs, et al.
Publicado: (2022)

ApmA Is a Unique Aminoglycoside Antibiotic Acetyltransferase That Inactivates Apramycin
por: Bordeleau, Emily, et al.
Publicado: (2021)

Modification at the 2′-Position of the 4,5-Series of 2-Deoxystreptamine Aminoglycoside Antibiotics To Resist Aminoglycoside Modifying Enzymes and Increase Ribosomal Target Selectivity
por: Sati, Girish C., et al.
Publicado: (2019)

Evaluation of automated systems for aminoglycosides and fluoroquinolones susceptibility testing for Carbapenem-resistant Enterobacteriaceae
por: Zhao, Zhichang, et al.
Publicado: (2017)

In vitro Activity of Apramycin Against Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Isolates
por: Hao, Mingju, et al.
Publicado: (2020)

Aminoglycoside Susceptibility Agreement between an Automated System and Broth Microdilution for Carbapenem-resistant Enterobacteriaceae
por: Kulengowski, Brandon, et al.
Publicado: (2017)

Population pharmacokinetics of apramycin from first-in-human plasma and urine data to support prediction of efficacious dose
por: Zhao, Chenyan, et al.
Publicado: (2022)

Epidemiological characteristics of carbapenem-resistant Enterobacteriaceae and carbapenem-resistant Acinetobacter baumannii in a tertiary referral hospital in Korea
por: Kang, Sollan, et al.
Publicado: (2022)

Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems
por: Karakonstantis, Stamatis, et al.
Publicado: (2020)

Maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed. Part 2: Aminoglycosides/aminocyclitols: apramycin, paromomycin, neomycin and spectinomycin
por: Allende, Ana, et al.
Publicado: (2021)

Novel Aminoglycoside Resistance Transposons and Transposon-Derived Circular Forms Detected in Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates
por: Karah, Nabil, et al.
Publicado: (2016)

Characterization of Resistance Patterns and Detection of Apramycin Resistance Genes in Escherichia coli Isolated from Chicken Feces and Houseflies after Apramycin Administration
por: Zhang, Anyun, et al.
Publicado: (2018)

Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075
por: Anderson, Sarah E., et al.
Publicado: (2018)

Wild-type cutoff for Apramycin against Escherichia coli
por: Yang, Yuqi, et al.
Publicado: (2020)

Characterization and utilization of methyltransferase for apramycin production in Streptoalloteichus tenebrarius
por: Sun, Junyang, et al.
Publicado: (2022)

Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
por: Wang, Jann-Tay, et al.
Publicado: (2015)

Resistance Pattern of Carbapenem on Enterobacteriaceae
por: Pokharel, Khilasa, et al.
Publicado: (2018)

Co-occurrence of carbapenem and aminoglycoside resistance genes among multidrug-resistant clinical isolates of Acinetobacter baumannii from Cracow, Poland
por: Nowak, Paweł, et al.
Publicado: (2014)

Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran
por: Mortazavi, S.M., et al.
Publicado: (2020)

Combination Therapy with Aminoglycoside in Bacteremiasdue to ESBL-Producing Enterobacteriaceae in ICU
por: Benetazzo, Lucie, et al.
Publicado: (2020)

Prevalence of Aminoglycoside Resistance Genes in Acinetobacter baumannii Isolates
por: Aliakbarzade, Katayun, et al.
Publicado: (2014)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

Pharmacokinetics and relative bioavailability of an oral amoxicillin-apramycin combination in pigs
por: Dai, Chongshan, et al.
Publicado: (2017)

Exogenous Citrulline and Glutamine Contribute to Reverse the Resistance of Salmonella to Apramycin
por: Yong, Yan, et al.
Publicado: (2021)

Vital Signs: Carbapenem-Resistant Enterobacteriaceae
por: Jacob, Jesse T., et al.
Publicado: (2013)

2430. Impact of USCAST Proposed Breakpoint Changes to Aminoglycosides, Cyclines, and Levofloxacin on Carbapenem-Resistant Enterobacteriaceae at a US Tertiary Referral Academic Medical Center
por: Kulengowski, Brandon, et al.
Publicado: (2018)

Hygromycin B and Apramycin Antibiotic Resistance Cassettes for Use in Campylobacter jejuni
por: Cameron, Andrew, et al.
Publicado: (2014)

Clinical Breakpoint of Apramycin to Swine Salmonella and Its Effect on Ileum Flora
por: Dai, Xinyu, et al.
Publicado: (2022)

Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii
por: Chang, Kang, et al.
Publicado: (2022)

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
por: Falagas, Matthew E., et al.
Publicado: (2014)

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
por: Morrill, Haley J., et al.
Publicado: (2015)

Factors associated with acquisition of carbapenem-resistant Enterobacteriaceae
por: Lavagnoli, Lilian Silva, et al.
Publicado: (2017)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
por: Jean, Shio-Shin, et al.
Publicado: (2018)

Emerging superbugs: The threat of Carbapenem Resistant Enterobacteriaceae
por: Dong, Le Thanh, et al.
Publicado: (2020)

Evaluation of Resistance Mechanisms in Carbapenem-Resistant Enterobacteriaceae
por: Alizadeh, Naser, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gcrt7u42h7v016d2744r6dnt2d